Skip to main content

Table 4 Medication History

From: Real-life use of onabotulinumtoxinA for symptom relief in patients with chronic migraine: REPOSE study methodology and baseline data

 

6-Month Completers

(n = 336)

Previous headache medication, n (%)a

 

 Beta blockers

238 (70.8)

 Antidepressants

235 (69.9)

 Antiepileptics

227 (67.6)

 Calcium channel blockers

102 (30.4)

 Botulinum toxin

24 (7.1)

Medication/therapy prescribed in the 26 weeks before baseline, n (%)a

 

 Any headache medication/therapy

305 (90.8)

 Acute treatment for headache

283 (84.2)

 Headache prevention

211 (62.8)

 Complementary therapies

73 (21.7)

Medication/therapy prescribed in the 26 weeks before baseline and used by the patient at baseline, n (%) a,b

 

 Headache prevention

168 (50.0)

  Topiramate

57 (17.0)

 Acute treatment for headache

271 (80.7)

  Sumatriptan

95 (28.3)

  Ibuprofen

75 (22.3)

  Rizatriptan

43 (12.8)

  Zolmitriptan

40 (11.9)

 Complementary therapies

49 (14.6)

  1. aMultiple answers were possible
  2. bMedications/therapies which were used at baseline by at least 10% of the patients